AbstrACt: Phyllodes tumor is attributed to a small fraction of primary tumors of the breast. Such tumors occur rarely in pregnancy and lactation. We report a case of a 25-year-old lactating mother presenting with a lump in the left breast. Core needle biopsy was opined as phyllodes tumor with lactational changes, and subsequent wide local excision confirmed the diagnosis of benign phyllodes tumor with lactational changes. The characteristic gross and microscopic findings of a well-circumscribed lesion with leaf-like fibroepithelial growth pattern and typical nonuniform or diffuse stromal proliferation with periductal accentuation even in the absence of mitotic figures can help clinch the diagnosis. Benign phyllodes is known for its recurrence and requires wide excision and close follow-up. It is vital to identify these lesions even on limited biopsies as therapeutic options differ. This case is presented for its rarity and the diagnostic challenge it poses in limited biopsy. 
Introduction
Phyllodes tumor accounts for a minor proportion of all fibroepithelial tumors of the breast (2.5%). It is postulated that these tumors arise de novo from intralobular or periductal stroma or rarely in a background of a fibroadenoma. Usually, it occurs as a unilateral well-circumscribed mass and can grow rapidly. According to the World Health Organization guidelines, phyllodes tumor is graded according to a three-tier classification into benign, borderline, and malignant tumors. Phyllodes tumor is rarely encountered during pregnancy and lactation. Timely identification is essential for appropriate therapy and risk stratification.
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Case Findings
A 25-year-old lactating mother (G2 P2) presented 8 months postpartum to the surgical outpatient department of our hospital on noticing a lump in her left breast associated with pain and difficulty in breastfeeding. She observed that the lump was progressively increasing in size, and she was facing difficulty in breastfeeding. There was no other significant medical or surgical history. The patient has given consent for publication of this report.
Clinical examination at our hospital indicated that the lump was present in the left breast located in the upper inner, lower inner, and central quadrant. Further workup included a core biopsy (Fig. 1A-C) that revealed a neoplastic lesion with leaf-like configuration lined by bilayered epithelial and myoepithelial cells and cellular fibrous stroma. Adjacent parenchyma demonstrated closely apposed acini lined by foamy cells harboring amorphous pale eosinophilic secretions within their lumina. The case was signed out as benign phyllodes tumor with lactational changes. The other investigations included routine hematological tests, liver function test, complete urine examination, blood urea, serum creatinine, random blood sugar, serum Thyroid stimulating hormone (TSH), and chest X-ray. These investigations were within normal limits.
Subsequently, the patient underwent wide local excision of the lump with a wide margin. The specimen consisted of a large grayish-white soft tissue mass measuring 10 cm × 9 cm × 4 cm covered on one aspect by a small ellipse of skin measuring 6 cm × 3 cm (Fig. 2) . The cut surface showed a relatively circumscribed lesion with grayish-white solid and cystic areas exuding thick milky fluid.
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of phyllodes tumors during pregnancy or lactation as benign, borderline or malignant, and unilateral or bilateral in 14 cases. 1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The findings of the present case of benign phyllodes tumor with lactational changes is concurrent with a case described previously by Likhitmaskul et al. 1 in a 36-year-old pregnant woman who underwent mastectomy 3 weeks postpartum. Generally, phyllodes tumor presents as a relatively circumscribed painless mass. On an average, the size of the tumor measures 4-5 cm; however, large tumors .10 cm have been described. On transection, it appears as grayish-white to tan with slit-like spaces and bulging cut surface. Microscopic findings include fibroepithelial proliferation in a classic leaflike pattern. The compressed ducts are lined by a bilayered epithelial and myoepithelial cells with expansile stroma and tumor. Immunohistochemical stains showed no expression of p53, CD117, CD10, and CD34. Proliferation index (Ki 67) was ,1%. The final diagnosis rendered was benign phyllodes tumor of the breast with lactational changes.
discussion
Phyllodes tumor is attributed to a small fraction of primary tumors of the breast (∼1%).
1,2 Such tumors occur rarely in pregnancy and lactation. Previous studies indicated occurrence mitotic activity, stromal overgrowth, and well-defined or pushing margins. 2 In view of tumor heterogeneity, the tumor has to be sampled extensively for accurate grading. Benign tumors demonstrate mild cellular stroma, well-defined tumor borders, lack of stromal atypia or mild atypia, and less than five mitotic figures per 10 high power fields with the absence of stromal overgrowth. Approximately 60%-75% of phyllodes tumors are reported as benign when compared to borderline and malignant phyllodes tumors. Borderline tumors have moderately cellular stroma, five to nine mitotic figures per 10 high power fields with mild-to-moderate atypia, whereas malignant tumors exhibit marked cellularity, atypia, brisk mitotic activity (.10/10 high power fields), infiltrative borders, and stromal overgrowth. 2, 3 Lactating breast demonstrates lobules of closely packed acini lined by vacuolated secretory epithelium with sparse intervening stroma and pale eosinophilic secretions within their lumina.
The important differential diagnosis includes lactating adenoma, fibroadenoma, galactocele, and periductal stromal tumor. [17] [18] [19] [20] It is vital to distinguish between them as therapeutic options differ. Fibroadenomas usually have scant stromal cellularity and lack mitotic activity, whereas phyllodes tumor exhibits an increase in stromal cellularity, especially adjoining the epithelium at the epithelial stromal interface with low mitotic activity. Similarly, periductal stromal tumor has overlapping histological features similar to phyllodes tumor; however, the former is not circumscribed with spindle cell proliferation around open tubules and lacks the leaf-like growth pattern with compressed tubules typically seen in the latter. Phyllodes tumor is rare in lactating breasts because the lactating breast normally demonstrates lobular and acinar hyperplasia to meet the physiological function and requirement during lactation. Therefore, it could be hypothesized accentuation sub jacent to the epithelium. Stromal overgrowth is characterized by the absence of ductal elements in at least one low power field and is predominantly demonstrated in tumors of increasing grade. The tumor can be graded based on the extent of stromal cellularity, nuclear pleomorphism, that as stromal hyperplasia is not a feature of lactating breast, the probability of development of phyllodes tumor is low.
Age, ethnicity, and genetic factors may be contributing factors as it has been reported that Asian woman may present with phyllodes at a younger age group (second-third decades) when compared to the western population. 2 Currently, there are no molecular markers of proven clini cal benefit. A recent study by Yoshida et al. 21 demonstrated that MED12 mutations were frequent among the phyllodes tumors of the breast, regardless of the tumor grade. On the contrary, few authors have shown that MED12 mutations are more common in fibroadenomas and benign phyllodes tumors than their malignant counterparts. 22 There are studies indicating increased expression of CD117, p53, ki67, VEGF, and several other markers with increasing tumor grade.
2 CD117 expression by stromal cells in phyllodes tumors has been shown to correlate with high grade, suggesting a possible role of CD117 being used as adjunctive marker of malignancy in these tumors. C-kit receptor-mediated tyrosine kinase involvement in the pathogenesis of phyllodes tumors has also been suggested by Tse et al. 23 CD10 expression in stromal cells of phyllodes tumor is reported to correlate with increasing grade. 24 There was no expression of CD10 in the stromal cells in this study. According to the current NCCN guidelines, conservative surgery with adequate resection-free margins is the treatment of choice. In cases of large tumors with doubtful margin status, simple mastectomy is undertaken.
The patient opted for breast conservation surgery with wide local excision. Generally, benign phyllodes tumor is associated with good prognosis; however, it is known for local recurrence (10%-17%) and requires wide excision and close follow-up. 2, 25 This patient at six months follow-up is doing well. 
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